A global innovation ecosystem and early-stage investor accelerating advanced AI applications in healthcare.
About Tenity
Tenity is a Zurich-based global innovation ecosystem and early-stage investor accelerating advanced AI applications including in healthcare, with stage focus on pre-seed and seed and checks below $250k. AI is an explicit focus, and the fund operates as a hybrid program-plus-fund model with a meaningful global footprint that extends beyond Switzerland into Singapore, Spain, and Italy. Healthcare interest centers on digital health and AI/ML in healthcare. The right founder for Tenity is an early technical team, often emerging from European or Asian academic or industry research, building defensible AI-native software with healthcare as a primary or near-term vertical, including imaging AI, clinical decision support, drug discovery tools, and healthcare workflow automation. The wrong founder is a consumer wellness brand, a regulated medtech hardware team, or a Series A-ready company looking for an institutional lead. Intro paths run through Zurich’s deep technology and biotech ecosystem including ETH Zurich, EPFL, and University of Zurich networks, frequent program partners including SIX Group, Julius Baer, and other Tenity-affiliated corporates, and through European healthcare AI investors such as Sofinnova, Earlybird, and HV Capital who occasionally co-invest at later stages. Direct application through Tenity’s program cycles is the standard entry, with warm intros from prior cohort founders or program partners materially accelerating diligence. In the pitch, lead with the technical depth: model architecture, training data approach, and a realistic view of what is solved versus aspirational, since Tenity’s global brand attracts strong applications and weak technical claims will be filtered out quickly. Show clinical or operational pilot evidence where possible and a credible regulatory pathway under EMA or FDA. Be specific about your data architecture, GDPR and Swiss FADP compliance, and the structure of any partnerships with healthcare data providers. Show how the program’s global reach into Asia or southern Europe creates real commercial leverage for your business, since Tenity’s value proposition is not just capital. Caveats include the standard accelerator dynamics: equity is taken at formation, follow-on commitment varies by cohort, and Tenity’s downstream signaling in the US is more limited than at Y Combinator or Techstars. For European or Asian healthcare AI technical founders, Tenity is a credible early partner with genuine global network depth.
Founder reviews
Other portfolio companies
Companies in Tenity's portfolio not currently in our directory.
- Look Up! · 2026
- neurodAIgnostics · 2026
- Medinexify · 2026
- Bloom AI · 2025
- SimCaseAI · 2025
- Citus · 2025
- Healactively · 2025
- Safespace Research · 2025
- Smilamind · 2025
- juli · 2024
- adamcares · 2024
- PhenomX Health · 2024
Team
Pitch / review this investor
Have you raised from Tenity? Founders only — share your honest experience (anonymous OK, moderated before publishing).